According to Vision Research Reports, the global linear particle accelerators market size surpassed at US$ 2.4 Bn in 2019 and to reach US$ 4.4 billion by 2027 with a CAGR of 6% from 2020 to 2027.
Linear accelerator is used to deliver external beam radiation for the treatment of cancer. The LINAC system customizes high-energy electrons to take the shape of the tumor to be treated, and destroy cancerous cells without affecting the surrounding tissues. Healthcare professionals such as radiation oncologists work in collaboration with dosimetrists and physicians to decide over the radiation treatment plan and appropriate mode of radiation treatment to be delivered.
A LINAC system is programmed before each radiation therapy session to deliver high-energy X-rays. The radiation takes specific size & shape and tracks the location of a tumor. The system has built-in protective measures that are designed to prevent excess dosages delivered, which can be higher than the prescribed amount. Radiation therapists ensure that the intensity of radiation beam is constant by using a device called tracker.
In terms of type, the global linear particle accelerators market has been classified into low-energy machine, medium-energy machine, and high-energy machine. The low-energy machine segment captured the largest market share in 2019 and the trend is anticipated to continue during the forecast period. The segment is expected to be driven by increase in use of low-energy LINAC systems for treatment of breast cancer and rise in availability of low-energy LINAC systems. Based on end user, the global linear particle accelerators market has been categorized into hospitals, ambulatory care centers, and research centers. The hospitals segment held major share of the global market in 2019, owing to increase in installation of LINAC systems, demand for sophisticated treatment modalities for cancer, and use of linear accelerators for treatment of a broad range of tumors.
The increase in the global geriatric population is another factor driving the global linear particle accelerators market. According to Cancer Research U.K., people aged between 50 and 74 account for over half (53%) of all new cancer cases, with slightly more cases in males than females.
Production of New Linear Particle Accelerators to Decline amid COVID-19
The onset of the COVID-19 pandemic is anticipated to have a slight impact on the overall growth of the global linear particle accelerators market, particularly in 2020. Due to the dwindling demand from hospitals, ambulatory centers, and research centers amid the ongoing COVID-19 pandemic due to increasing focus on catering to the patients suffering from the novel of COVID-19 infection, the production of linear particle accelerators is likely to remain lower than the initial projections. However, on the research front, activities are likely to remain normal without any major interference from governments.
Research and Development Activities Offer Growth Opportunities
Research and development is expected to remain one of the most critical factors that will drive the growth of the global market for linear particle accelerators during the forecast period. With the onset of novel technologies and focus on automating the tuning process of the beam, scientists are exploring the possibilities of operating linear particle accelerators with a diminishing direction from humans. Several researchers and scientists are increasingly investing resources to automate various aspects of linear particle accelerators for the past two to three decades. Moreover, as per current trends, the next-generation of linear particle accelerators are likely to be highly automated– a factor that is expected to aid the growth of the global linear particle accelerators market in the upcoming decade.
Advancements in machine learning are increasingly being utilized for problem detection, optimizing beam lines, and create real-time simulations. At the back of these factors and other promising research outcomes, the global linear particle accelerators market is on the course to have a steady growth rate during the forecast period.
Demand for Linear Particle Accelerators to Treat Resistant Tumors on Rise
The number of ‘advanced’ cancer cases around the world has witnessed consistent growth in recent years, owing to a combination of both, poor lifestyle choices and genetic factors. Some of the conventional and popular cancer treatments, including chemotherapy and radiation have gained considerable popularity in the medical space over the past couple of decades. However, linear particle accelerators have emerged as one of the most promising alternative advanced treatments for resistant tumors and as per the current observations, the adoption is anticipated to witness a spike in the upcoming years. Research and development activities are expected to play a key role in the overall development of the global linear particle accelerators market during the forecast period. In recent years, medical experts around the world are increasing merging MRI with linear particle accelerators to improve the precision in cancer treatment– a factor that is anticipated to bolster the growth of the global linear particle accelerators market in stipulated timeframe of the study.
North America held a major share of the global linear particle accelerators market in 2019. Increase in demand for integrated treatment solutions in oncology and shift from the use of traditional radiation therapy to LINAC are the key factors driving the market in the region. Europe held the second largest share of the global linear particle accelerators market in 2019. The growth of the linear particle accelerators market in the region can be attributed to high adoption of newer technology systems and increase in incidence of breast cancer. According to Globocon, in 2018, Europe had 4,229,662 cancer cases. Breast cancer accounted for nearly 12.4% of newly diagnosed cases in 2018. Incidence of breast cancer was higher among women than in men. Colorectal cancer and lung cancer accounted for nearly 11.8% and 10.6% of newly diagnosed cases in the same year.
Leading players are expanding their footprint to strengthen their positions in the global linear particle accelerators market. Development of innovative oncology systems, technological advancements, and geographic expansion by prominent market players are likely to present lucrative opportunities in the global linear particle accelerators market. Key players operating in the global linear particle accelerators market include Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, Shinva Medical Instrument Co., Ltd., and Viewray Medical Technologies Inc.
By End User
Acromegaly Treatment Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028Read more...
Cancer Immunotherapy Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028Read more...
Preterm Birth and PROM Testing Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028Read more...
Anti-aging Services Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028Read more...
Veterinary Pain Management Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2028Read more...